|
Market Closed -
NSE India S.E.
06:05:05 2026-02-10 am EST
|
5-day change
|
1st Jan Change
|
|
887.30 INR
|
-3.91%
|
 |
-1.73%
|
-2.96%
|
|
Nov. 07 |
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,120 From INR1,150, Keeps at Buy
|
MT
| |
Nov. 04 |
Zydus Lifesciences Limited Receives Tentative Approval from USFDA for Budesonide Delayed-Release Capsules, 4 Mg
|
CI
| |
25-05-21 |
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,150 From INR1,350, Keeps at Buy
|
MT
| |
25-03-10 |
Zydus Lifesciences Limited entered into a tender offer agreement to acquire 14.40% stake in Amplitude Surgical SA for ?43.2 million.
|
CI
| |
25-02-06 |
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,350 From INR1,380, Keeps at Buy
|
MT
| |
25-01-10 |
Nomura Upgrades Zydus Lifesciences to Buy From Neutral, Adjusts Price Target to INR1,140 From INR1,030
|
MT
| |
24-11-14 |
Nomura Adjusts Zydus Lifesciences' Price Target to INR1,030 From INR1,020, Keeps at Neutral
|
MT
| |
24-11-13 |
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,380 From INR1,450, Keeps at Buy
|
MT
| |
24-08-28 |
Jefferies Upgrades Zydus Lifesciences to Buy From Hold, Adjusts Price Target to INR1,450 From INR1,210
|
MT
| |
24-08-12 |
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,210 From INR1,070, Keeps at Hold
|
MT
| |
24-05-21 |
Nomura Downgrades Zydus Lifesciences to Neutral From Buy, Adjusts Price Target to INR1,020 From INR988
|
MT
| |
24-05-20 |
Jefferies Adjusts Zydus Lifesciences' Price Target to INR1,070 From INR750, Keeps at Hold
|
MT
| |
24-02-12 |
Jefferies Adjusts Zydus Lifesciences’ Price Target to INR750 From INR660, Keeps at Hold
|
MT
| |
23-11-08 |
Jefferies Adjusts Zydus Lifesciences’ Price Target to INR640 From INR630, Keeps at Hold
|
MT
| |
23-08-15 |
Nomura Adjusts Zydus Lifesciences' Price Target to INR747 From INR540, Keeps at Buy
|
MT
| |
23-08-14 |
Jefferies Downgrades Zydus Lifesciences to Hold From Buy, Adjusts Price Target to INR630 From INR585
|
MT
| |
23-05-19 |
Jefferies Adjusts Zydus Lifesciences' Price Target to INR585 From INR575, Keeps at Buy
|
MT
| |
23-02-07 |
Nomura Adjusts Zydus Lifesciences' Price Target to INR540 From INR489, Keeps at Buy
|
MT
| |
22-02-07 |
Nomura Adjusts Cadila Healthcare's Price Target to 489 Indian Rupees From 481 Indian Rupees, Keeps at Buy
|
MT
| |
21-08-23 |
Mindtree : Indian shares reverse gains as metals drag; Cadila jumps
|
RE
| |
15-05-15 |
Cadila Healthcare Ltd Recommends Dividend for the Year Ended March 31, 2015, payable on or after August 17, 2015
|
CI
| |
12-05-09 |
Cadila Healthcare Limited Recommends Dividend
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
